Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. www.accessdata.fda.gov › drugsatfda_docs › labelORTHO EVRA® (norelgestromin / ethinyl estradiol TRANSDERMAL...

   www.accessdata.fda.gov › drugsatfda_docs › label

   DESCRIPTION. ORTHO EVRA® is a combination transdermal contraceptive patch with a contact surface area of 20 cm2. It contains 6.00 mg norelgestromin (NGMN) and 0.75 mg ethinyl estradiol (EE).

2. www.ema.europa.eu › product-information › evra-epar-product-information_enANNEX I SUMMARY OF PRODUCT CHARACTERISTICS - European Medicines...

   www.ema.europa.eu › product-information › evra-epar-product-information_en

   1. NAME OF THE MEDICINAL PRODUCT. EVRA 203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patch. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION. Each 20 cm2 transdermal patch contains 6 mg norelgestromin (NGMN) and 600 micrograms ethinyl estradiol (EE).

3. cdn.mdedge.com › files › s3fs-publicORTHO EVRA (NORELGESTROMIN / ETHINYL ESTRADIOL TRANSDERMAL...

   cdn.mdedge.com › files › s3fs-public

   ORTHO EVRA® is a combination transdermal contraceptive patch with a contact surface area of 20 cm 2 .It contains 6.00 mg norelgestromin and 0.75 mg ethinyl estradiol (EE),and releases 150 micrograms of norelgestromin and 20 micrograms of EE to the bloodstream per 24 hours.

4. www.accessdata.fda.gov › drugsatfda_docs › labelThis label may not be the latest approved by FDA. For current...

   www.accessdata.fda.gov › drugsatfda_docs › label

   ORTHO EVRA is an estrogen/progestin combination hormonal contraceptive (CHC), indicated for the prevention of pregnancy in women who elect to use a transdermal patch. (1) Limitation of Use:...

5. pdf.hres.ca › dpd_pm › 00065628PRODUCT MONOGRAPH - pdf.hres.ca

   pdf.hres.ca › dpd_pm › 00065628

   FORMS, COMPOSITION AND PACKAGING section. INDICATIONS AND CLINICAL USE The EVRA® (norelgestromin and ethinyl estradiol) transdermal system is indicated for the prevention of pregnancy. The pharmacokinetic profile for the EVRA® transdermal system is different from that of an oral contraceptive.

6. contracept.org › docs › orthoevraORTHO EVRA™ (NORELGESTROMIN / ETHINYL ESTRADIOL TRANSDERMAL...

   contracept.org › docs › orthoevra

   ORTHO EVRATM is a combination transdermal contraceptive patch with a contact surface area of 20 cm2. It contains 6.00 mg norelgestromin and 0.75 mg ethinyl estradiol (EE), and releases 150 micrograms of norelgestromin and 20 micrograms of EE to the bloodstream per 24 hours.

7. www.medicines.org.uk › emc › filesPackage leaflet: Information for the user Important things to...

   www.medicines.org.uk › emc › files

   norelgestromin/ethinyl estradiol. Important things to know about combined hormonal contraceptives (CHCs): They are one of the most reliable reversible methods of contraception if used correctly. ly in the first year or when restarting a combined hormonal contraceptive following a break of 4 or more w.